Targeted delivery systems for biological therapies of inflammatory diseases
Introduction: Inflammatory diseases, including autoimmune diseases and autoinflammatory
diseases, are characterized by the imbalance of pro-inflammatory cytokines and anti …
diseases, are characterized by the imbalance of pro-inflammatory cytokines and anti …
Bioresponsive drug delivery systems for the treatment of inflammatory diseases
Y Dou, C Li, L Li, J Guo, J Zhang - Journal of controlled release, 2020 - Elsevier
Inflammation is intimately related to the pathogenesis of numerous acute and chronic
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases
Inflammation is an immune response that marks several pathophysiological conditions in
our body. Though adaptive immune cells play a major role in the progression of the disease …
our body. Though adaptive immune cells play a major role in the progression of the disease …
Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases
Macrophages play a key role in defending against foreign pathogens, healing wounds, and
regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which …
regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which …
Emerging drug delivery systems with traditional routes–A roadmap to chronic inflammatory diseases
Inflammation is prevalent and inevitable in daily life but can generally be accommodated by
the immune systems. However, incapable self-healing and persistent inflammation can …
the immune systems. However, incapable self-healing and persistent inflammation can …
[HTML][HTML] Macrophage based drug delivery: Key challenges and strategies
Q Guo, ZM Qian - Bioactive Materials, 2024 - Elsevier
As a natural immune cell and antigen presenting cell, macrophages have been studied and
engineered to treat human diseases. Macrophages are well-suited for use as drug carriers …
engineered to treat human diseases. Macrophages are well-suited for use as drug carriers …
[HTML][HTML] Macrophage-related therapeutic strategies: regulation of phenotypic switching and construction of drug delivery systems
X Wang, Y Li, X Pu, G Liu, H Qin, W Wan… - Pharmacological …, 2023 - Elsevier
Macrophages, as highly phenotypic plastic immune cells, play diverse roles in different
pathological conditions. Changing and controlling the phenotypes of macrophages is …
pathological conditions. Changing and controlling the phenotypes of macrophages is …
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
A Zaid, A Ariel - Advanced Drug Delivery Reviews, 2024 - Elsevier
Targeting specific organs and cell types using nanotechnology and sophisticated delivery
methods has been at the forefront of applicative biomedical sciences lately. Macrophages …
methods has been at the forefront of applicative biomedical sciences lately. Macrophages …
Recent advances in liposomal-based anti-inflammatory therapy
CMA van Alem, JM Metselaar, C van Kooten… - Pharmaceutics, 2021 - mdpi.com
Liposomes can be seen as ideal carriers for anti-inflammatory drugs as their ability to
(passively) target sites of inflammation and release their content to inflammatory target cells …
(passively) target sites of inflammation and release their content to inflammatory target cells …
Macrophage-targeted therapeutics for metabolic disease
Macrophages are cells of the innate immune system that are resident in all tissues, including
metabolic organs such as the liver and adipose tissue (AT). Because of their phenotypic …
metabolic organs such as the liver and adipose tissue (AT). Because of their phenotypic …
相关搜索
- inflammatory diseases biological therapies
- chronic inflammatory diseases
- inflammatory diseases drug delivery
- treatment of inflammatory diseases
- inflammatory diseases drug carriers
- anti-inflammatory therapy
- delivery strategies context of inflammation
- phenotypic switching therapeutic strategies
- immune homeostasis context of inflammation